← All diseases Cancer

Anaplastic thyroid carcinoma

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest level of evidence only (20)Meta-analysis (9)Treatment guideline (3)Systematic review (6)Phase 3 study (2)Clinical trial (90)Review article (144)Early study (phase 1 or 2) (46)Case report (144)Laboratory or animal study (46)Commentary or editorial (16)Retracted publication (3) Studies currently recruiting participants only (32)

Filter

Publications and studies (1124)

• High Prevalence of TBC1D12 5'UTR Mutations in Anaplastic Thyroid Cancer. (2025/01/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Neoadjuvant Therapy of Unresectable Anaplastic Thyroid Cancer. (2025/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. New Horizons of Biomarkers in Metastatic Thyroid Cancer. (2025/01/01) ♡
• Phase 3 studyiResearch in a large group of patients, the final step before a treatment can be approved. What comes out here carries significant weight. DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers. (2025-11-24) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. XL092 and Cemiplimab in BRAF WT Thyroid Cancer (2025-11-05) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Vudalimab for the Treatment of Locally Advanced or Metastatic Anaplastic Thyroid Cancer or Hurthle Cell Thyroid Cancer (2025-10-20) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors (2025-10-02) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Efficacy of Pembrolizumab and Lenvatinib in Patients With Anaplastic Thyroid Cancer (2025-09-05) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. JSI-1187-01 Monotherapy and in Combination With Dabrafenib for Advanced Solid Tumors With MAPK Pathway Mutations (2025-09-03) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Taiwanese Anaplastic Thyroid Cancer Registry (2025-08-22) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Trial of Cabozantinib Plus Atezolizumab in Advanced and Progressive Neoplasms of the Endocrine System. The CABATEN Study (2025-06-19) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Nivolumab Plus Ipilimumab in Thyroid Cancer (2025-06-19) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Abemaciclib in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer (2025-06-05) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors (2025-05-08) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Study of AIC100 CAR T Cells in Relapsed/Refractory Thyroid Cancer (2025-03-30) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Clinical Study of NKG2D CAR-NK Combined with PD-1 Monoclonal Antibody in the Treatment of ATC (2025-03-04) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Inolitazone Dihydrochloride and Paclitaxel in Treating Patients With Advanced Anaplastic Thyroid Cancer (2025-01-27) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Emerging Insights Into Thyroid Cancer From Immunotherapy Perspective: A Bibliometric Analysis. (2024/12/31) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Osteosarcoma Metastatic to the Thyroid Gland: A Rare Case Report. (2024/12/27) ♡
• Metastatic Anaplastic Thyroid Carcinoma to the Right Ventricle. (2024/12/18) ♡
• The Potential Therapeutic Value of Aspirin in Anaplastic Thyroid Cancer. (2024/12/17) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Efficacy and Safety of Pazopanib in the Treatment of Thyroid Cancer: A Systematic Review. (2024/12/12) ♡
• The Correlation Between Biological Markers and Prognosis in Thyroid Cancer. (2024/12/12) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Anaplastic Thyroid Cancer: A Review of Recent Evidence and Summary of an Australian Institutional Protocol. (2024/12/01) ♡
• Disparities in Postoperative Adjuvant Therapy Utilization and Factors Impacting Survival Among Anaplastic Thyroid Cancer Patients. (2024/12/01) ♡
• Combination Kinase Inhibitors and Immunotherapy for Unresectable Anaplastic Thyroid Carcinoma: A Retrospective Single-Center Study. (2024/12/01) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Dual Immune Checkpoint Inhibition in Patients With Aggressive Thyroid Carcinoma: A Phase 2 Nonrandomized Clinical Trial. (2024/12/01) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Anti-Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma: A Nonrandomized Clinical Trial. (2024/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Combination Therapy With BRAF and MEK Inhibitors for Anaplastic Thyroid Cancer: A Report of Two Cases. (2024/12/01) ♡
• Unravelling the Reasons Behind Limited Response to Anti-PD Therapy in ATC: A Comprehensive Evaluation of Tumor-Infiltrating Immune Cells and Checkpoints. (2024/12/01) ♡
• SATB2 Is an Emergent Biomarker of Anaplastic Thyroid Carcinoma: A Series With Comprehensive Biomarker and Molecular Studies. (2024/12/01) ♡
• [Special Entities of the Head and Neck Region: Cancers of the Nasopharynx, (Para)nasal Cavities, Salivary Glands, and the Thyroid Gland: Post ASCO 2024]. (2024/12/01) ♡
• Anaplastic Thyroid Carcinoma: The Great Masquerader. (2024/12/01) ♡
• Consensus Statement: Recommendations on Actionable Biomarker Testing for Thyroid Cancer Management. (2024/12/01) ♡
• Clinicopathologic and Molecular Analysis of 15 Pediatric and Young Adult Patients With High-Grade Non-anaplastic Thyroid Carcinoma. (2024/12/01) ♡
• Validation of two predictive models for survival in anaplastic thyroid cancer (ATC). (2024/11/29) ♡
• YTHDF2 Promotes Anaplastic Thyroid Cancer Progression by Activating the DDIT4/AKT/mTOR Signaling Pathway. (2024/11/26) ♡
• Thyroidectomy. (2024/11/25) ♡
• Radioactive Iodine Therapy for Thyroid Malignancies. (2024/11/25) ♡
• Could SLC26A7 Be a Promising Marker for Preoperative Diagnosis of High-Grade Papillary Thyroid Carcinoma? (2024/11/25) ♡
• Identification and Validation of a Novel Prognostic Signature and Key Genes Related to Development of Anaplastic Thyroid Carcinoma. (2024/11/19) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Anaplastic thyroid carcinoma: vimentin segregates at the invasive front of tumors in a murine xenograft model. (2024/11/18) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Advanced Unresectable Differentiated Thyroid Cancer With Anaplastic Transformation: A Case Report and Review of the Literature. (2024/11/18) ♡
• Development and validation of survival nomograms for patients with anaplastic thyroid carcinoma: a SEER program-based study. (2024/11/13) ♡
• Correction: ISG15 and ISGylation modulates cancer stem cell-like characteristics in promoting tumor growth of anaplastic thyroid carcinoma. (2024/11/13) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Multidisciplinary Canadian consensus on the multimodal management of high-risk and radioactive iodine-refractory thyroid carcinoma. (2024/11/04) ♡
• EIF1AX mutation in thyroid nodules: a histopathologic analysis of 56 cases in the context of institutional practices. (2024/11/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Anaplastic transformation of metastatic papillary thyroid carcinoma lesion histologically mimicking a squamous cell carcinoma: A case report. (2024/11/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. The Cancer-Specific Health Economic Measure QLU-C10D is Valid and Responsive for Assessing Health Utility in Patients with Thyroid Cancer. (2024/11/01) ♡
• Clinically aggressive follicular cell-derived thyroid carcinoma: A comprehensive series with histomolecular characterization and discovery of novel gene fusions. (2024/11/01) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.